Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | alkB, alkylation repair homolog 3 (E. coli) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | Get druggable targets OG5_134523 | All targets in OG5_134523 |
Mycobacterium tuberculosis | Conserved hypothetical protein | Get druggable targets OG5_134523 | All targets in OG5_134523 |
Mycobacterium leprae | Conserved hypothetical protein | Get druggable targets OG5_134523 | All targets in OG5_134523 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0027 | 0.0217 | 0.5 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0027 | 0.0217 | 0.5 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0027 | 0.0217 | 0.033 |
Onchocerca volvulus | 0.0057 | 0.1019 | 1 | |
Mycobacterium leprae | Conserved hypothetical protein | 0.023 | 0.5679 | 1 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0027 | 0.0217 | 0.033 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0217 | 0.1888 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.0599 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0027 | 0.0217 | 0.033 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.0599 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0021 | 0.003 | 0.0053 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0021 | 0.003 | 0.5 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0027 | 0.0217 | 0.033 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0027 | 0.0217 | 0.033 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0027 | 0.0217 | 0.0382 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0027 | 0.0217 | 0.5 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0027 | 0.0217 | 0.033 |
Brugia malayi | hypothetical protein | 0.0042 | 0.0599 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0027 | 0.0217 | 0.033 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.0599 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0027 | 0.0217 | 0.0382 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0217 | 0.1888 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.0599 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0027 | 0.0217 | 0.033 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.023 | 0.5679 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0021 | 0.003 | 0.5 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0021 | 0.003 | 0.5 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0057 | 0.1019 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.023 | 0.5679 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.1019 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0217 | 0.1888 |
Echinococcus multilocularis | tumor protein p63 | 0.0391 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 4.5 uM | Inhibition of demethylase activity of PCA-1 (unknown origin) using 3-methyl cytosine oligo DNA as substrate after 1 hr by RT-PCR analysis | ChEMBL. | 24461353 |
Inhibition (functional) | = 87 % | Antiproliferative activity against human DU145 cells at 10 uM after 7 days by 3-D agar-based WST-assay | ChEMBL. | 24461353 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.